Study of Icotinib Hydrochloride Cream in Patients With Mild to Moderate Psoriasis
Clinical trial NCT03222622 · TERMINATED
Trial details
- NCT number
- NCT03222622
- Sponsor
- Betta Pharmaceuticals Co., Ltd.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-29
- Primary completion
- 2018-08-15
- Enrollment
- 136
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.